메뉴 건너뛰기




Volumn 2017, Issue 3, 2017, Pages

Deprescribing versus continuation of chronic proton pump inhibitor use in adults

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

EID: 85015369624     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011969.pub2     Document Type: Review
Times cited : (18)

References (148)
  • 1
    • 84963540059 scopus 로고    scopus 로고
    • Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
    • 5309779
    • Bayerdörffer E, Bigard MA, Weiss W, Mearin F, Rodrigo L, Munoz JED, et al. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease. BMC Gastroenterology 2016;16(48):1-12. 5309779
    • (2016) BMC Gastroenterology , vol.16 , Issue.48 , pp. 1-12
    • Bayerdörffer, E.1    Bigard, M.A.2    Weiss, W.3    Mearin, F.4    Rodrigo, L.5    Munoz, J.E.D.6
  • 2
    • 16444386234 scopus 로고    scopus 로고
    • Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment
    • 5309781
    • Bour B, Staub J-L, Chousterman M, Labayle F, Nalet B, Nouel O, et al. Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. Alimentary Pharmacology & Therapeutics 2005;21(7):805-12. 5309781
    • (2005) Alimentary Pharmacology & Therapeutics , vol.21 , Issue.7 , pp. 805-812
    • Bour, B.1    Staub, J.-L.2    Chousterman, M.3    Labayle, F.4    Nalet, B.5    Nouel, O.6
  • 3
    • 24944500837 scopus 로고    scopus 로고
    • Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease: once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term
    • 5309783
    • Janssen W, Meier E, Gatz G, Pfaffenberger B. Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease: once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term. Current Therapeutic Research, Clinical and Experimental 2005;66(4):345-63. 5309783
    • (2005) Current Therapeutic Research, Clinical and Experimental , vol.66 , Issue.4 , pp. 345-363
    • Janssen, W.1    Meier, E.2    Gatz, G.3    Pfaffenberger, B.4
  • 4
    • 39149145452 scopus 로고    scopus 로고
    • Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg
    • 5309785
    • Morgan DG, O'Mahony MFJ, O'Mahony WF, Roy J, Camacho F, Dinniwell J, et al. Maintenance treatment of gastroesophageal reflux disease: an evaluation of continuous and on-demand therapy with rabeprazole 20 mg. Canadian Journal of Gastroenterology 2007;21(12):820-6. 5309785
    • (2007) Canadian Journal of Gastroenterology , vol.21 , Issue.12 , pp. 820-826
    • Morgan, D.G.1    O'Mahony, M.F.J.2    O'Mahony, W.F.3    Roy, J.4    Camacho, F.5    Dinniwell, J.6
  • 5
    • 0038772379 scopus 로고    scopus 로고
    • Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole
    • 5309787
    • Pilotto A, Leandro G, Franceschi M, Ageing and Acid-Related Disease Study Group. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole. Alimentary Pharmacology & Therapeutics 2003;17(11):1399-406. 5309787
    • (2003) Alimentary Pharmacology & Therapeutics , vol.17 , Issue.11 , pp. 1399-1406
    • Pilotto, A.1    Leandro, G.2    Franceschi, M.3
  • 6
    • 72149090914 scopus 로고    scopus 로고
    • Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial
    • 5309789
    • Van der Velden AW, de Wit NJ, Quartero AO, Grobbee DE, Numans ME. Pharmacological dependency in chronic treatment of gastroesophageal reflux disease: a randomized controlled clinical trial. Digestion 2010;81(1):43-52. 5309789
    • (2010) Digestion , vol.81 , Issue.1 , pp. 43-52
    • Van der Velden, A.W.1    de Wit, N.J.2    Quartero, A.O.3    Grobbee, D.E.4    Numans, M.E.5
  • 7
    • 0031873984 scopus 로고    scopus 로고
    • Omeprazole in patient with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment
    • 5309791
    • Annibale B, Franceschi M, Fusillo M, Beni M, Cesana B, Delle Fave G. Omeprazole in patient with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment. Hepato-Gastroenterology 1998;45(21):742-51. 5309791
    • (1998) Hepato-Gastroenterology , vol.45 , Issue.21 , pp. 742-751
    • Annibale, B.1    Franceschi, M.2    Fusillo, M.3    Beni, M.4    Cesana, B.5    Delle Fave, G.6
  • 8
    • 0023920203 scopus 로고
    • Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief
    • 5309793
    • Archambault AP, Pare P, Bailey RJ, Navert H, Williams CN, Freeman HJ. Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 1988;94(5 Pt 1):1130-4. 5309793
    • (1988) Gastroenterology , vol.94 , Issue.5 PART. 1 , pp. 1130-1134
    • Archambault, A.P.1    Pare, P.2    Bailey, R.J.3    Navert, H.4    Williams, C.N.5    Freeman, H.J.6
  • 9
    • 0025145951 scopus 로고
    • Omeprazole or ranitidine for reflux oesophagitis: comment
    • 5309795
    • Bardhan KD. Omeprazole or ranitidine for reflux oesophagitis: comment. National Medical Journal of India 1990;3(1):20-1. 5309795
    • (1990) National Medical Journal of India , vol.3 , Issue.1 , pp. 20-21
    • Bardhan, K.D.1
  • 11
    • 0024453018 scopus 로고
    • Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer
    • 5309799
    • Bate CM, Wilkinson SP, Bradby GV, Bateson MC, Hislop WS, Crowe JP, et al. Randomized, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 1989;30(10):1323-8. 5309799
    • (1989) Gut , vol.30 , Issue.10 , pp. 1323-1328
    • Bate, C.M.1    Wilkinson, S.P.2    Bradby, G.V.3    Bateson, M.C.4    Hislop, W.S.5    Crowe, J.P.6
  • 12
    • 0025061538 scopus 로고
    • Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic and histological evaluations
    • 5309801
    • Bate CM, Keeling PW, O'Morain C, Wilkinson SP, Foster DN, Mountford RA, et al. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic and histological evaluations. Gut 1990;31(9):968-72. 5309801
    • (1990) Gut , vol.31 , Issue.9 , pp. 968-972
    • Bate, C.M.1    Keeling, P.W.2    O'Morain, C.3    Wilkinson, S.P.4    Foster, D.N.5    Mountford, R.A.6
  • 13
    • 0028968545 scopus 로고
    • Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis
    • 5309803
    • Bate CM, Booth SN, Crowe JP, Mountford RA, Keeling PW, Hepworth-Jones B, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995;36(4):492-8. 5309803
    • (1995) Gut , vol.36 , Issue.4 , pp. 492-498
    • Bate, C.M.1    Booth, S.N.2    Crowe, J.P.3    Mountford, R.A.4    Keeling, P.W.5    Hepworth-Jones, B.6
  • 14
    • 0030959728 scopus 로고    scopus 로고
    • Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis
    • 5309805
    • Bate CM, Green JR, Axon AT, Murray FE, Tildesley G, Emmas CE, et al. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis. Alimentary Pharmacology & Therapeutics 1997;11(4):755-63. 5309805
    • (1997) Alimentary Pharmacology & Therapeutics , vol.11 , Issue.4 , pp. 755-763
    • Bate, C.M.1    Green, J.R.2    Axon, A.T.3    Murray, F.E.4    Tildesley, G.5    Emmas, C.E.6
  • 15
    • 33750904767 scopus 로고    scopus 로고
    • The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: what is the evidence?
    • 5309807
    • Bautista JM. The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: what is the evidence?. Journal of Gastroenterology and Hepatology 2006;21(Suppl 5):S112-4. 5309807
    • (2006) Journal of Gastroenterology and Hepatology , vol.21 , pp. S112-S114
    • Bautista, J.M.1
  • 17
    • 26244460778 scopus 로고    scopus 로고
    • Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg
    • 5309811
    • Bigard MA, Genestin E. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg. Alimentary Pharmacology & Therapeutics 2005;22(7):635-43. 5309811
    • (2005) Alimentary Pharmacology & Therapeutics , vol.22 , Issue.7 , pp. 635-643
    • Bigard, M.A.1    Genestin, E.2
  • 18
  • 19
    • 3242890564 scopus 로고    scopus 로고
    • Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease
    • 5309815
    • Bytzer P, Blum A, De Herdt D, Dubois D. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Alimentary Pharmacology & Therapeutics 2004;20(2):181-8. 5309815
    • (2004) Alimentary Pharmacology & Therapeutics , vol.20 , Issue.2 , pp. 181-188
    • Bytzer, P.1    Blum, A.2    De Herdt, D.3    Dubois, D.4
  • 20
    • 19244380563 scopus 로고    scopus 로고
    • Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole
    • 5309817
    • Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. European Journal of Gastroenterology & Hepatology 1998;10(2):119-24. 5309817
    • (1998) European Journal of Gastroenterology & Hepatology , vol.10 , Issue.2 , pp. 119-124
    • Carlsson, R.1    Dent, J.2    Watts, R.3    Riley, S.4    Sheikh, R.5    Hatlebakk, J.6
  • 22
    • 78650871536 scopus 로고    scopus 로고
    • The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease
    • 5309821
    • Dabholkar AH, Han C, Paris MM, Perez MC, Atkinson SN, Peura DA. The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2011;33(3):366-77. 5309821
    • (2011) Alimentary Pharmacology & Therapeutics , vol.33 , Issue.3 , pp. 366-377
    • Dabholkar, A.H.1    Han, C.2    Paris, M.M.3    Perez, M.C.4    Atkinson, S.N.5    Peura, D.A.6
  • 23
    • 0242301200 scopus 로고    scopus 로고
    • Lansoprazole 15 mg OD is superior to ranitidine 300 mg OD in relieving heartburn and healing patients with (endoscopically confirmed) reflux oesophagitis grade I Le lansoprazole 15 mg OD est superieur a la ranitidine 300 mg OD dans le soulagement du pyrosis et pour guerison des patient souffrant d'oesophagite de reflux de grade I (confirme par endoscopie)]
    • 5309823
    • Deboever G, Wagner C, Bourgeois N, Muls V, Belaiche J, Azerad M-A, et al. Lansoprazole 15 mg OD is superior to ranitidine 300 mg OD in relieving heartburn and healing patients with (endoscopically confirmed) reflux oesophagitis grade I [Le lansoprazole 15 mg OD est superieur a la ranitidine 300 mg OD dans le soulagement du pyrosis et pour guerison des patient souffrant d'oesophagite de reflux de grade I (confirme par endoscopie)]. Acta Endoscopica 2003;33(4):573-85. 5309823
    • (2003) Acta Endoscopica , vol.33 , Issue.4 , pp. 573-585
    • Deboever, G.1    Wagner, C.2    Bourgeois, N.3    Muls, V.4    Belaiche, J.5    Azerad, M.-A.6
  • 25
    • 0028337366 scopus 로고
    • Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety
    • 5309827
    • Dent J, Yeomans ND, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ, et al. Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994;35(5):590-8. 5309827
    • (1994) Gut , vol.35 , Issue.5 , pp. 590-598
    • Dent, J.1    Yeomans, N.D.2    Mackinnon, M.3    Reed, W.4    Narielvala, F.M.5    Hetzel, D.J.6
  • 26
    • 33745739304 scopus 로고    scopus 로고
    • Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams
    • 5309829
    • DeVault KR, Johanson JF, Johnson DA, Liu S, Sostek MB. Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams. Clinical Gastroenterology and Hepatology 2006;4(7):852-9. 5309829
    • (2006) Clinical Gastroenterology and Hepatology , vol.4 , Issue.7 , pp. 852-859
    • DeVault, K.R.1    Johanson, J.F.2    Johnson, D.A.3    Liu, S.4    Sostek, M.B.5
  • 28
    • 63849322408 scopus 로고    scopus 로고
    • Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg
    • 5309833
    • Eggleston A, Katelaris PH, Nandurkar S, Thorpe P, Holtmann G. Clinical trial: the treatment of gastro-oesophageal reflux disease in primary care - prospective randomized comparison of rabeprazole 20 mg with esomeprazole 20 and 40 mg. Alimentary Pharmacology & Therapeutics 2009;29(9):967-78. 5309833
    • (2009) Alimentary Pharmacology & Therapeutics , vol.29 , Issue.9 , pp. 967-978
    • Eggleston, A.1    Katelaris, P.H.2    Nandurkar, S.3    Thorpe, P.4    Holtmann, G.5
  • 30
    • 0033885191 scopus 로고    scopus 로고
    • Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial
    • 5309837
    • Farley A, Wruble LD, Humphries TJ. Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. American Journal of Gastroenterology 2000;95(8):1894-9. 5309837
    • (2000) American Journal of Gastroenterology , vol.95 , Issue.8 , pp. 1894-1899
    • Farley, A.1    Wruble, L.D.2    Humphries, T.J.3
  • 31
    • 79952359320 scopus 로고    scopus 로고
    • The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD
    • 5309839
    • Fass R, Johnson DA, Orr WC, Han C, Mody R, Stern KN, et al. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. American Journal of Gastroenterology 2011;106(3):421-31. 5309839
    • (2011) American Journal of Gastroenterology , vol.106 , Issue.3 , pp. 421-431
    • Fass, R.1    Johnson, D.A.2    Orr, W.C.3    Han, C.4    Mody, R.5    Stern, K.N.6
  • 32
    • 84857195670 scopus 로고    scopus 로고
    • Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release
    • 5309841
    • Fass R, Inadomi J, Han C, Mody R, O'Neil J, Perez MC. Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release. Clinical Gastroenterology and Hepatology 2012;10(3):247-53. 5309841
    • (2012) Clinical Gastroenterology and Hepatology , vol.10 , Issue.3 , pp. 247-253
    • Fass, R.1    Inadomi, J.2    Han, C.3    Mody, R.4    O'Neil, J.5    Perez, M.C.6
  • 33
    • 68149111568 scopus 로고    scopus 로고
    • Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects
    • 5309843
    • Fennerty MB, Peura DA, Riff DS, Snoddy AM. Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. Alimentary Pharmacology & Therapeutics 2009;30(5):459-68. 5309843
    • (2009) Alimentary Pharmacology & Therapeutics , vol.30 , Issue.5 , pp. 459-468
    • Fennerty, M.B.1    Peura, D.A.2    Riff, D.S.3    Snoddy, A.M.4
  • 34
    • 0028939088 scopus 로고
    • Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study
    • 5309845
    • Goh KL, Boonyapisit S, Lai KH, Chang R, Kang JY, Lam SK. Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study. Journal of Gastroenterology and Hepatology 1995;10(1):92-7. 5309845
    • (1995) Journal of Gastroenterology and Hepatology , vol.10 , Issue.1 , pp. 92-97
    • Goh, K.L.1    Boonyapisit, S.2    Lai, K.H.3    Chang, R.4    Kang, J.Y.5    Lam, S.K.6
  • 35
    • 33847013013 scopus 로고    scopus 로고
    • Efficacy of pantoprazole 20mg daily compared with esomeprazole 20mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study
    • 5309847
    • Goh KL, Benamouzig R, Sander P, Schwan T. Efficacy of pantoprazole 20mg daily compared with esomeprazole 20mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study. European Journal of Gastroenterology & Hepatology 2007;19(3):205-11. 5309847
    • (2007) European Journal of Gastroenterology & Hepatology , vol.19 , Issue.3 , pp. 205-211
    • Goh, K.L.1    Benamouzig, R.2    Sander, P.3    Schwan, T.4
  • 37
    • 0030942154 scopus 로고    scopus 로고
    • Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis
    • 5309851
    • Hatlebakk JG, Berstad A. Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis. Alimentary Pharmacology & Therapeutics 1997;11(2):365-72. 5309851
    • (1997) Alimentary Pharmacology & Therapeutics , vol.11 , Issue.2 , pp. 365-372
    • Hatlebakk, J.G.1    Berstad, A.2
  • 38
    • 0030834490 scopus 로고    scopus 로고
    • Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole
    • 5309853
    • Hatlebakk JG, Berstad A. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole. Alimentary Pharmacology & Therapeutics 1997;11(6):1093-9. 5309853
    • (1997) Alimentary Pharmacology & Therapeutics , vol.11 , Issue.6 , pp. 1093-1099
    • Hatlebakk, J.G.1    Berstad, A.2
  • 39
    • 0023870395 scopus 로고
    • Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial
    • 5309855
    • Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. BMJ 1988;296(6515):89-92. 5309855
    • (1988) BMJ , vol.296 , Issue.6515 , pp. 89-92
    • Havelund, T.1    Laursen, L.S.2    Skoubo-Kristensen, E.3    Andersen, B.N.4    Pedersen, S.A.5    Jensen, K.B.6
  • 40
    • 0029064626 scopus 로고
    • Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?
    • 5309857
    • Hoshino E, Umeda N, Sano J, Miki K, Yahagi N, Oka M, et al. Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?. Journal of Clinical Gastroenterology 1995;20(Suppl 2):S72-4. 5309857
    • (1995) Journal of Clinical Gastroenterology , vol.20 , pp. S72-S74
    • Hoshino, E.1    Umeda, N.2    Sano, J.3    Miki, K.4    Yahagi, N.5    Oka, M.6
  • 41
    • 0034972797 scopus 로고    scopus 로고
    • Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies
    • 5309859
    • Howden CW, Henning JM, Huang B, Lukasik N, Freston JW. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies. American Journal of Gastroenterology 2001;96(6):1704-10. 5309859
    • (2001) American Journal of Gastroenterology , vol.96 , Issue.6 , pp. 1704-1710
    • Howden, C.W.1    Henning, J.M.2    Huang, B.3    Lukasik, N.4    Freston, J.W.5
  • 42
    • 70349687374 scopus 로고    scopus 로고
    • Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief
    • 5309861
    • Howden CW, Larsen LM, Perez MC, Palmer R, Atkinson SN. Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief. Alimentary Pharmacology & Therapeutics 2009;30(9):895-907. 5309861
    • (2009) Alimentary Pharmacology & Therapeutics , vol.30 , Issue.9 , pp. 895-907
    • Howden, C.W.1    Larsen, L.M.2    Perez, M.C.3    Palmer, R.4    Atkinson, S.N.5
  • 43
    • 84927772444 scopus 로고    scopus 로고
    • Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis
    • 5309863
    • Hsu PI, Lu CL, Wu DC, Kuo CH, Kao SS, Chang CC, et al. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis. Clinical Gastroenterology and Hepatology 2015;13(5):859-66. 5309863
    • (2015) Clinical Gastroenterology and Hepatology , vol.13 , Issue.5 , pp. 859-866
    • Hsu, P.I.1    Lu, C.L.2    Wu, D.C.3    Kuo, C.H.4    Kao, S.S.5    Chang, C.C.6
  • 45
    • 0141621818 scopus 로고    scopus 로고
    • Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPI
    • 5309867
    • Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPI. American Journal of Gastroenterology 2003;98(9):1940-4. 5309867
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.9 , pp. 1940-1944
    • Inadomi, J.M.1    McIntyre, L.2    Bernard, L.3    Fendrick, A.M.4
  • 46
    • 0028288454 scopus 로고
    • Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis
    • 5309869
    • James OF, Parry-Billings KS. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis. Age and Ageing 1994;23(2):121-6. 5309869
    • (1994) Age and Ageing , vol.23 , Issue.2 , pp. 121-126
    • James, O.F.1    Parry-Billings, K.S.2
  • 47
    • 0035137990 scopus 로고    scopus 로고
    • Esomeprazole once daily for 6 months Is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
    • 5309871
    • Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, et al. Esomeprazole once daily for 6 months Is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety. American Journal of Gastroenterology 2001;96(1):27-34. 5309871
    • (2001) American Journal of Gastroenterology , vol.96 , Issue.1 , pp. 27-34
    • Johnson, D.A.1    Benjamin, S.B.2    Vakil, N.B.3    Goldstein, J.L.4    Lamet, M.5    Whipple, J.6
  • 48
    • 77953775776 scopus 로고    scopus 로고
    • Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances
    • 5309873
    • Johnson D, Crawley JA, Hwang C, Krown B. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances. Alimentary Pharmacology & Therapeutics 2010;32(2):182-90. 5309873
    • (2010) Alimentary Pharmacology & Therapeutics , vol.32 , Issue.2 , pp. 182-190
    • Johnson, D.1    Crawley, J.A.2    Hwang, C.3    Krown, B.4
  • 49
    • 0030854608 scopus 로고    scopus 로고
    • Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice
    • 5309875
    • Jones RH, Baxter G. Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice. Alimentary Pharmacology & Therapeutics 1997;11(3):541-6. 5309875
    • (1997) Alimentary Pharmacology & Therapeutics , vol.11 , Issue.3 , pp. 541-546
    • Jones, R.H.1    Baxter, G.2
  • 50
    • 57649166895 scopus 로고    scopus 로고
    • On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor
    • 5309877
    • Juul-Hansen P, Rydning A. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor. Alimentary Pharmacology & Therapeutics 2008;29(2):207-12. 5309877
    • (2008) Alimentary Pharmacology & Therapeutics , vol.29 , Issue.2 , pp. 207-212
    • Juul-Hansen, P.1    Rydning, A.2
  • 51
    • 0033822910 scopus 로고    scopus 로고
    • Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia
    • 5309879
    • Kaplan-Machlis B, Spiegler GE, Zodet MW, Revicki DA. Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia. Archives of Family Medicine 2000;9(7):624-30. 5309879
    • (2000) Archives of Family Medicine , vol.9 , Issue.7 , pp. 624-630
    • Kaplan-Machlis, B.1    Spiegler, G.E.2    Zodet, M.W.3    Revicki, D.A.4
  • 52
    • 23944433411 scopus 로고    scopus 로고
    • Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease
    • 5309881
    • Kaspari S, Kupcinskas L, Heinze H, Berghöfer P. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease. European Journal of Gastroenterology & Hepatology 2005;17(9):935-41. 5309881
    • (2005) European Journal of Gastroenterology & Hepatology , vol.17 , Issue.9 , pp. 935-941
    • Kaspari, S.1    Kupcinskas, L.2    Heinze, H.3    Berghöfer, P.4
  • 53
    • 0023115291 scopus 로고
    • Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis
    • 5309883
    • Klinkenberg-Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987;1(8529):349-51. 5309883
    • (1987) Lancet , vol.1 , Issue.8529 , pp. 349-351
    • Klinkenberg-Knol, E.C.1    Jansen, J.M.2    Festen, H.P.3    Meuwissen, S.G.4    Lamers, C.B.5
  • 54
    • 77953647407 scopus 로고    scopus 로고
    • Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole
    • 5309885
    • Kovacs TO, Freston JW, Haber MM, Atkinson S, Hunt B, Peura DA. Long-term quality of life improvement in subjects with healed erosive esophagitis: treatment with lansoprazole. Digestive Diseases and Sciences 2010;55(5):1325-36. 5309885
    • (2010) Digestive Diseases and Sciences , vol.55 , Issue.5 , pp. 1325-1336
    • Kovacs, T.O.1    Freston, J.W.2    Haber, M.M.3    Atkinson, S.4    Hunt, B.5    Peura, D.A.6
  • 55
    • 27644521903 scopus 로고    scopus 로고
    • Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study
    • 5309887
    • Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, et al. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Alimentary Pharmacology & Therapeutics 2005;22(9):803-11. 5309887
    • (2005) Alimentary Pharmacology & Therapeutics , vol.22 , Issue.9 , pp. 803-811
    • Labenz, J.1    Armstrong, D.2    Lauritsen, K.3    Katelaris, P.4    Schmidt, S.5    Schütze, K.6
  • 57
    • 0033034891 scopus 로고    scopus 로고
    • On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial
    • 5309891
    • Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen SA, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial. Alimentary Pharmacology & Therapeutics 1999;13(7):907-14. 5309891
    • (1999) Alimentary Pharmacology & Therapeutics , vol.13 , Issue.7 , pp. 907-914
    • Lind, T.1    Havelund, T.2    Lundell, L.3    Glise, H.4    Lauritsen, K.5    Pedersen, S.A.6
  • 58
    • 0026083103 scopus 로고
    • Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine
    • 5309893
    • Lundell L, Backman L, Ekström P, Enander LK, Falkmer S, Fausa O, et al. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine. Scandinavian Journal of Gastroenterology 1991;26(3):248-56. 5309893
    • (1991) Scandinavian Journal of Gastroenterology , vol.26 , Issue.3 , pp. 248-256
    • Lundell, L.1    Backman, L.2    Ekström, P.3    Enander, L.K.4    Falkmer, S.5    Fausa, O.6
  • 59
    • 0037253272 scopus 로고    scopus 로고
    • Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis
    • 5309895
    • Metz DC, Bochenek WJ. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Alimentary Pharmacology & Therapeutics 2003;17(1):155-64. 5309895
    • (2003) Alimentary Pharmacology & Therapeutics , vol.17 , Issue.1 , pp. 155-164
    • Metz, D.C.1    Bochenek, W.J.2
  • 60
    • 84896918492 scopus 로고    scopus 로고
    • A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan
    • 5309897
    • Nagahara A, Hojo M, Asaoka D, Sasaki H, Watanabe S. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan. Scandinavian Journal of Gastroenterology 2014;49(4):409-17. 5309897
    • (2014) Scandinavian Journal of Gastroenterology , vol.49 , Issue.4 , pp. 409-417
    • Nagahara, A.1    Hojo, M.2    Asaoka, D.3    Sasaki, H.4    Watanabe, S.5
  • 61
    • 77954424083 scopus 로고    scopus 로고
    • Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial
    • 5309899
    • Niklasson A, Lindström L, Simrén M, Lindberg G, Björnsson E. Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial. American Journal of Gastroenterology 2010;105(7):1531-7. 5309899
    • (2010) American Journal of Gastroenterology , vol.105 , Issue.7 , pp. 1531-1537
    • Niklasson, A.1    Lindström, L.2    Simrén, M.3    Lindberg, G.4    Björnsson, E.5
  • 62
    • 23844554227 scopus 로고    scopus 로고
    • A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease
    • 5309901
    • Norman Hansen A, Bergheim R, Fagertun H, Lund H, Moum B. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease. International Journal of Clinical Practice 2005;59(6):665-71. 5309901
    • (2005) International Journal of Clinical Practice , vol.59 , Issue.6 , pp. 665-671
    • Norman Hansen, A.1    Bergheim, R.2    Fagertun, H.3    Lund, H.4    Moum, B.5
  • 63
    • 68149111568 scopus 로고    scopus 로고
    • Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects
    • 5309903
    • Peura DA, Riff DS, Snoddy AM, Fennerty MB. Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self-treating subjects. Alimentary Pharmacology & Therapeutics 2009;30(5):459-68. 5309903
    • (2009) Alimentary Pharmacology & Therapeutics , vol.30 , Issue.5 , pp. 459-468
    • Peura, D.A.1    Riff, D.S.2    Snoddy, A.M.3    Fennerty, M.B.4
  • 64
    • 84978493459 scopus 로고    scopus 로고
    • A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction
    • 5309905
    • Peura D, Le Moigne A, Pollack C, Nagy P, Lind T. A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction. Postgraduate Medical Journal 2016;128(6):577-83. 5309905
    • (2016) Postgraduate Medical Journal , vol.128 , Issue.6 , pp. 577-583
    • Peura, D.1    Le Moigne, A.2    Pollack, C.3    Nagy, P.4    Lind, T.5
  • 65
    • 3543002869 scopus 로고    scopus 로고
    • On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction
    • 5309907
    • Ponce J, Argüello L, Bastida G, Ponce M, Ortiz V, Garrigues V. On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction. Digestive Diseases and Sciences 2004;49(6):931-6. 5309907
    • (2004) Digestive Diseases and Sciences , vol.49 , Issue.6 , pp. 931-936
    • Ponce, J.1    Argüello, L.2    Bastida, G.3    Ponce, M.4    Ortiz, V.5    Garrigues, V.6
  • 66
    • 77957582373 scopus 로고    scopus 로고
    • Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse
    • 5309909
    • Reimer C, Bytzer P. Discontinuation of long-term proton pump inhibitor therapy in primary care patients: a randomized placebo-controlled trial in patients with symptom relapse. European Journal of Gastroenterology & Hepatology 2010;22(10):1182-8. 5309909
    • (2010) European Journal of Gastroenterology & Hepatology , vol.22 , Issue.10 , pp. 1182-1188
    • Reimer, C.1    Bytzer, P.2
  • 67
    • 0033759926 scopus 로고    scopus 로고
    • Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial
    • 5309911
    • Richter JE, Bochenek W. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. American Journal of Gastroenterology 2000;95(11):3071-80. 5309911
    • (2000) American Journal of Gastroenterology , vol.95 , Issue.11 , pp. 3071-3080
    • Richter, J.E.1    Bochenek, W.2
  • 70
    • 0023922956 scopus 로고
    • Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study
    • 5309917
    • Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scandinavian Journal of Gastroenterology 1988;23(5):625-32. 5309917
    • (1988) Scandinavian Journal of Gastroenterology , vol.23 , Issue.5 , pp. 625-632
    • Sandmark, S.1    Carlsson, R.2    Fausa, O.3    Lundell, L.4
  • 71
    • 24944540256 scopus 로고    scopus 로고
    • On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial
    • 5309919
    • Scholten T, Dekkers CP, Schütze K, Körner T, Bohuschke M, Gatz G. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial. Digestion 2005;72(2-3):76-85. 5309919
    • (2005) Digestion , vol.72 , Issue.2-3 , pp. 76-85
    • Scholten, T.1    Dekkers, C.P.2    Schütze, K.3    Körner, T.4    Bohuschke, M.5    Gatz, G.6
  • 72
    • 23844557524 scopus 로고    scopus 로고
    • Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis
    • 5309921
    • Sjöstedt S, Befrits R, Sylvan A, Harthon C, Jörgensen L, Carling L, et al. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Alimentary Pharmacology & Therapeutics 2005;22(3):183-91. 5309921
    • (2005) Alimentary Pharmacology & Therapeutics , vol.22 , Issue.3 , pp. 183-191
    • Sjöstedt, S.1    Befrits, R.2    Sylvan, A.3    Harthon, C.4    Jörgensen, L.5    Carling, L.6
  • 73
    • 8244237721 scopus 로고    scopus 로고
    • Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study
    • 5309923
    • Sontag SJ, Robinson M, Roufail W, Hirschowitz BI, Sabesin SM, Wu WC, et al. Daily omeprazole surpasses intermittent dosing in preventing relapse of oesophagitis: a US multi-centre double-blind study. Alimentary Pharmacology & Therapeutics 1997;11(2):373-80. 5309923
    • (1997) Alimentary Pharmacology & Therapeutics , vol.11 , Issue.2 , pp. 373-380
    • Sontag, S.J.1    Robinson, M.2    Roufail, W.3    Hirschowitz, B.I.4    Sabesin, S.M.5    Wu, W.C.6
  • 74
    • 84930851098 scopus 로고    scopus 로고
    • Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis
    • 5309925
    • Sun J, Yuan YZ, Hou XH, Zou DW, Lu B, Chen MH, et al. Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis. World Journal of Gastroenterology 2015;21(22):6965-73. 5309925
    • (2015) World Journal of Gastroenterology , vol.21 , Issue.22 , pp. 6965-6973
    • Sun, J.1    Yuan, Y.Z.2    Hou, X.H.3    Zou, D.W.4    Lu, B.5    Chen, M.H.6
  • 75
    • 0035114856 scopus 로고    scopus 로고
    • Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months
    • 5309927
    • Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Alimentary Pharmacology & Therapeutics 2001;15(3):347-54. 5309927
    • (2001) Alimentary Pharmacology & Therapeutics , vol.15 , Issue.3 , pp. 347-354
    • Talley, N.J.1    Lauritsen, K.2    Tunturi-Hihnala, H.3    Lind, T.4    Moum, B.5    Bang, C.6
  • 76
    • 85087579476 scopus 로고    scopus 로고
    • Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care
    • 5309929
    • Talley N, Moore M, Sprogis A, Katelaris P. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care. Medical Journal of Australia 2002;117:415-9. 5309929
    • (2002) Medical Journal of Australia , vol.117 , pp. 415-419
    • Talley, N.1    Moore, M.2    Sprogis, A.3    Katelaris, P.4
  • 77
    • 0036667969 scopus 로고    scopus 로고
    • Esomeprazole 40 mg and 20 mg is efficacious in the long term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months
    • 5309931
    • Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. European Journal of Gastroenterology & Hepatology 2002;14(8):857-63. 5309931
    • (2002) European Journal of Gastroenterology & Hepatology , vol.14 , Issue.8 , pp. 857-863
    • Talley, N.J.1    Venables, T.L.2    Green, J.R.3    Armstrong, D.4    O'Kane, K.P.5    Giaffer, M.6
  • 78
    • 79960319148 scopus 로고    scopus 로고
    • Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial
    • 5309933
    • Tan VP, Wong WM, Cheung TK, Lai KC, Hung IF, Chan P, et al. Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial. Journal of Gastroenterology 2011;46(7):906-12. 5309933
    • (2011) Journal of Gastroenterology , vol.46 , Issue.7 , pp. 906-912
    • Tan, V.P.1    Wong, W.M.2    Cheung, T.K.3    Lai, K.C.4    Hung, I.F.5    Chan, P.6
  • 79
    • 4644234211 scopus 로고    scopus 로고
    • Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study
    • 5309935
    • Tsai HH, Chapman R, Shepherd A, McKeith D, Anderson M, Vearer D, et al. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study. Alimentary Pharmacology & Therapeutics 2004;20(6):657-65. 5309935
    • (2004) Alimentary Pharmacology & Therapeutics , vol.20 , Issue.6 , pp. 657-665
    • Tsai, H.H.1    Chapman, R.2    Shepherd, A.3    McKeith, D.4    Anderson, M.5    Vearer, D.6
  • 80
    • 0034949404 scopus 로고    scopus 로고
    • The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety
    • 5309937
    • Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, et al. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety. Alimentary Pharmacology & Therapeutics 2001;15:927-35. 5309937
    • (2001) Alimentary Pharmacology & Therapeutics , vol.15 , pp. 927-935
    • Vakil, N.B.1    Shaker, R.2    Johnson, D.A.3    Kovacs, T.4    Baerg, R.D.5    Hwang, C.6
  • 81
    • 0025852038 scopus 로고
    • U.S. experience with omeprazole in duodenal ulcer-multicenter double-blind comparative study with ranitidine
    • 5309939
    • Valenzuela J, Berlin R, Snape W, Johnson T, Hirschowitz B, Colon-Pagan J, et al. U.S. experience with omeprazole in duodenal ulcer-multicenter double-blind comparative study with ranitidine. Digestive Diseases and Sciences 1991;36(6):761-8. 5309939
    • (1991) Digestive Diseases and Sciences , vol.36 , Issue.6 , pp. 761-768
    • Valenzuela, J.1    Berlin, R.2    Snape, W.3    Johnson, T.4    Hirschowitz, B.5    Colon-Pagan, J.6
  • 84
    • 0023814934 scopus 로고
    • Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis
    • 5309945
    • Vantrappen G, Rutgeerts L, Schurmans P, Coenegrachts JL. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Digestive Diseases and Sciences 1988;33(5):523-9. 5309945
    • (1988) Digestive Diseases and Sciences , vol.33 , Issue.5 , pp. 523-529
    • Vantrappen, G.1    Rutgeerts, L.2    Schurmans, P.3    Coenegrachts, J.L.4
  • 85
    • 0034105983 scopus 로고    scopus 로고
    • Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study
    • 5309947
    • Van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, et al. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study. European Journal of Gastroenterology & Hepatology 2000;12(2):197-202. 5309947
    • (2000) European Journal of Gastroenterology & Hepatology , vol.12 , Issue.2 , pp. 197-202
    • Van Zyl, J.H.1    Grundling, H.2    van Rensburg, C.J.3    Retief, F.J.4    O'Keefe, S.J.5    Theron, I.6
  • 86
    • 0030862096 scopus 로고    scopus 로고
    • Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice
    • 5309949
    • Venables T, Newland R, Patel A, Hole J, Wilcock C, Turbitt M. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scandinavian Journal of Gastroenterology 1997;32:965-73. 5309949
    • (1997) Scandinavian Journal of Gastroenterology , vol.32 , pp. 965-973
    • Venables, T.1    Newland, R.2    Patel, A.3    Hole, J.4    Wilcock, C.5    Turbitt, M.6
  • 88
    • 0024560455 scopus 로고
    • Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial
    • 5309953
    • Danish Omeprazole Study Group. Omeprazole and cimetidine in the treatment of ulcers of the body of the stomach: a double blind comparative trial. BMJ 1989;298(6674):645-7. 5309953
    • (1989) BMJ , vol.298 , Issue.6674 , pp. 645-647
  • 90
    • 85015447161 scopus 로고    scopus 로고
    • Guideline for diagnosis and treatment of chronic undiagnosed dyspepsia in adults
    • June:
    • Alberta Clinical Practice Guideline Working Group. Guideline for diagnosis and treatment of chronic undiagnosed dyspepsia in adults. The Alberta Clinical Guideline Program 2000; Vol. June:1-10.
    • (2000) The Alberta Clinical Guideline Program , pp. 1-10
  • 95
    • 85015372263 scopus 로고    scopus 로고
    • Economic models and conclusions for the treatment of dyspepsia; and gastroesophageal reflux disease-related heartburn and the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal complications, 2007
    • (accessed 9 November 2015)
    • Canadian Agency for Drugs and Technologies in Health. Economic models and conclusions for the treatment of dyspepsia; and gastroesophageal reflux disease-related heartburn and the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal complications, 2007. www.cadth.ca/sites/default/files/compus/pdf/compus_economic_report_april-07_e.pdf (accessed 9 November 2015).
  • 96
    • 85015368069 scopus 로고    scopus 로고
    • GERD, 2015
    • (accessed 9 November 2015)
    • Canadian Digestive Health Foundation. GERD, 2015. www.cdhf.ca/en/statistics (accessed 9 November 2015).
  • 97
    • 85015413915 scopus 로고    scopus 로고
    • Top 100 Drugs
    • issue March
    • Canadian Healthcare Network. Top 100 Drugs. Pharmacy Practice 2013, issue March:1-25.
    • (2013) Pharmacy Practice , pp. 1-25
  • 98
    • 84869420958 scopus 로고    scopus 로고
    • Proton pump inhibitors: the good, the bad, and the unwanted
    • Chubineh S, Birk J. Proton pump inhibitors: the good, the bad, and the unwanted. Southern Medical Journal 2012;105(11):613-8.
    • (2012) Southern Medical Journal , vol.105 , Issue.11 , pp. 613-618
    • Chubineh, S.1    Birk, J.2
  • 100
    • 84906046732 scopus 로고    scopus 로고
    • Assessing the appropriate use of proton pump inhibitors in a veteran outpatient population
    • Dangler M, Ochs L, White R. Assessing the appropriate use of proton pump inhibitors in a veteran outpatient population. Federal Practitioner 2013;30(5):21-5.
    • (2013) Federal Practitioner , vol.30 , Issue.5 , pp. 21-25
    • Dangler, M.1    Ochs, L.2    White, R.3
  • 101
    • 17644416461 scopus 로고    scopus 로고
    • Epidemiology of gastro-oesophageal reflux disease: a systematic review
    • Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54(5):710-7.
    • (2005) Gut , vol.54 , Issue.5 , pp. 710-717
    • Dent, J.1    El-Serag, H.B.2    Wallander, M.A.3    Johansson, S.4
  • 103
    • 21844455031 scopus 로고    scopus 로고
    • Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease
    • Donnellan C, Preston C, Moayyedi P, Sharma N. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database of Systematic Reviews 2004, issue 4:CD003245. [DOI: 10.1002/14651858.CD003245.pub2]
    • (2004) Cochrane Database of Systematic Reviews , Issue.4
    • Donnellan, C.1    Preston, C.2    Moayyedi, P.3    Sharma, N.4
  • 106
    • 84861429145 scopus 로고    scopus 로고
    • Initiation and duration of proton pump inhibitors in the Australian veteran population
    • Gadzhanova SV, Roughead EE, Mackson JM. Initiation and duration of proton pump inhibitors in the Australian veteran population. Internal Medicine Journal 2012;42(5):e68-73.
    • (2012) Internal Medicine Journal , vol.42 , Issue.5 , pp. e68-e73
    • Gadzhanova, S.V.1    Roughead, E.E.2    Mackson, J.M.3
  • 107
    • 84991925924 scopus 로고    scopus 로고
    • 5th Edition. Mulgrave, Australia: Digestive Health Foundation
    • Gastroenterological Society of Australia. Gastro-oesophageal Reflux Disease in Adults. 5th Edition. Mulgrave, Australia: Digestive Health Foundation, 2011:10.
    • (2011) Gastro-oesophageal Reflux Disease in Adults , pp. 10
  • 108
    • 1842429782 scopus 로고    scopus 로고
    • Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer
    • Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz E. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Alimentary Pharmacology & Therapeutics 2004;19(6):617-29.
    • (2004) Alimentary Pharmacology & Therapeutics , vol.19 , Issue.6 , pp. 617-629
    • Gisbert, J.P.1    Khorrami, S.2    Carballo, F.3    Calvet, X.4    Gene, E.5    Dominguez-Munoz, E.6
  • 109
    • 84859706610 scopus 로고    scopus 로고
    • Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes
    • Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clinics in Geriatric Medicine 2012;28(2):237-53.
    • (2012) Clinics in Geriatric Medicine , vol.28 , Issue.2 , pp. 237-253
    • Gnjidic, D.1    Le Couteur, D.G.2    Kouladjian, L.3    Hilmer, S.N.4
  • 110
    • 84945937474 scopus 로고    scopus 로고
    • GRADEpro
    • Version accessed 7 December 2016. Hamilton (ON): GRADE Working Group, McMaster University
    • GRADE Working Group, McMaster University. GRADEpro. Version accessed 7 December 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
    • (2014)
  • 113
    • 84937039007 scopus 로고    scopus 로고
    • Strategies for discontinuation of proton pump inhibitors: a systematic review
    • Haastrup P, Paulsen M, Begtrup L, Hansen J, Jarbol D. Strategies for discontinuation of proton pump inhibitors: a systematic review. Family Practice 2014;31(6):625-30.
    • (2014) Family Practice , vol.31 , Issue.6 , pp. 625-630
    • Haastrup, P.1    Paulsen, M.2    Begtrup, L.3    Hansen, J.4    Jarbol, D.5
  • 114
    • 79952115955 scopus 로고    scopus 로고
    • Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting
    • Heidelbaugh JJ, Goldberg KL, Inadomi JM. Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. American Journal of Managed Care 2010;16(9):e228-34.
    • (2010) American Journal of Managed Care , vol.16 , Issue.9 , pp. e228-e234
    • Heidelbaugh, J.J.1    Goldberg, K.L.2    Inadomi, J.M.3
  • 115
    • 84887346660 scopus 로고    scopus 로고
    • Cochrane Handbook for Systematic Reviews of Interventions
    • Version 5.1.0 (updated March 2011). The Cochrane Collaboration
    • Higgins JPT Green S, editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.
    • (2011)
    • Higgins, J.P.T.1    Green, S.2
  • 117
    • 56649123507 scopus 로고    scopus 로고
    • Medication withdrawal trials in people aged 65 years and older: a systematic review
    • New Zealand: Adis International Ltd
    • Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs and Aging. New Zealand: Adis International Ltd, 2008; Vol. 25, issue 12:1021-31.
    • (2008) Drugs and Aging , vol.25 , Issue.12 , pp. 1021-1031
    • Iyer, S.1    Naganathan, V.2    McLachlan, A.J.3    Le Couteur, D.G.4
  • 118
    • 84885813143 scopus 로고    scopus 로고
    • Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis
    • Jiang Y-X, Chen Y, Kong X, Tong Y-L, Xu S-C. Maintenance treatment of mild gastroesophageal reflux disease with proton pump inhibitors taken on-demand: a meta-analysis. Hepato-gastroenterology 2013;60(125):1077-82.
    • (2013) Hepato-gastroenterology , vol.60 , Issue.125 , pp. 1077-1082
    • Jiang, Y.-X.1    Chen, Y.2    Kong, X.3    Tong, Y.-L.4    Xu, S.-C.5
  • 119
    • 84875225548 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of gastroesophageal reflux disease
    • United Kingdom: Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom)
    • Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. American Journal of Gastroenterology. United Kingdom: Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom), 2013; Vol. 108, issue 3:308-28.
    • (2013) American Journal of Gastroenterology , vol.108 , Issue.3 , pp. 308-328
    • Katz, P.O.1    Gerson, L.B.2    Vela, M.F.3
  • 121
    • 11144256984 scopus 로고    scopus 로고
    • Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?
    • Lee TJ, Fennerty MB, Howden CW. Systematic review: is there excessive use of proton pump inhibitors in gastro-oesophageal reflux disease?. Alimentary Pharmacology & Therapeutics 2004;20(11-12):1241-51.
    • (2004) Alimentary Pharmacology & Therapeutics , vol.20 , Issue.11-12 , pp. 1241-1251
    • Lee, T.J.1    Fennerty, M.B.2    Howden, C.W.3
  • 123
    • 84876058433 scopus 로고    scopus 로고
    • Reversing gears: discontinuing medication therapy to prevent adverse events
    • Linsky A, Simon SR. Reversing gears: discontinuing medication therapy to prevent adverse events. JAMA Internal Medicine 2013;173(7):524-5.
    • (2013) JAMA Internal Medicine , vol.173 , Issue.7 , pp. 524-525
    • Linsky, A.1    Simon, S.R.2
  • 124
    • 0032816679 scopus 로고    scopus 로고
    • Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification
    • Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45(2):172-80.
    • (1999) Gut , vol.45 , Issue.2 , pp. 172-180
    • Lundell, L.R.1    Dent, J.2    Bennett, J.R.3    Blum, A.L.4    Armstrong, D.5    Galmiche, J.P.6
  • 127
    • 48249126219 scopus 로고    scopus 로고
    • Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit
    • Murphy CE, Stevens AM, Ferrentino N, Crookes BA, Hebert JC, Freiburg CB, et al. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit. Pharmacotherapy 2008;28(8):968-76.
    • (2008) Pharmacotherapy , vol.28 , Issue.8 , pp. 968-976
    • Murphy, C.E.1    Stevens, A.M.2    Ferrentino, N.3    Crookes, B.A.4    Hebert, J.C.5    Freiburg, C.B.6
  • 128
    • 23944437345 scopus 로고    scopus 로고
    • Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease
    • Pace F, Negrini C, Wiklund I, Rossi C, Savarino V. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 2005;22:349-56.
    • (2005) Alimentary Pharmacology & Therapeutics , vol.22 , pp. 349-356
    • Pace, F.1    Negrini, C.2    Wiklund, I.3    Rossi, C.4    Savarino, V.5
  • 130
    • 29244438843 scopus 로고    scopus 로고
    • Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners
    • Raghunath AS, Hungin APS, Cornford CS, Featherstone V. Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners. Digestion 2005;72(4):212-8.
    • (2005) Digestion , vol.72 , Issue.4 , pp. 212-218
    • Raghunath, A.S.1    Hungin, A.P.S.2    Cornford, C.S.3    Featherstone, V.4
  • 131
    • 84874609858 scopus 로고    scopus 로고
    • Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderly
    • Reeve E, Wiese MD. Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderly. Drugs & Aging 2012;29(11):925-8.
    • (2012) Drugs & Aging , vol.29 , Issue.11 , pp. 925-928
    • Reeve, E.1    Wiese, M.D.2
  • 132
    • 84890247826 scopus 로고    scopus 로고
    • Patient barriers to and enablers of deprescribing: a systematic review
    • Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs & Aging 2013;30(10):793-807.
    • (2013) Drugs & Aging , vol.30 , Issue.10 , pp. 793-807
    • Reeve, E.1    To, J.2    Hendrix, I.3    Shakib, S.4    Roberts, M.S.5    Wiese, M.D.6
  • 133
    • 84919625780 scopus 로고    scopus 로고
    • Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors
    • Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Annals of Pharmacotherapy 2015;49(1):29-38.
    • (2015) Annals of Pharmacotherapy , vol.49 , Issue.1 , pp. 29-38
    • Reeve, E.1    Andrews, J.M.2    Wiese, M.D.3    Hendrix, I.4    Roberts, M.S.5    Shakib, S.6
  • 134
    • 69949152539 scopus 로고    scopus 로고
    • Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients
    • Reimer C, Bytzer P. Clinical trial: long-term use of proton pump inhibitors in primary care patients - a cross sectional analysis of 901 patients. Alimentary Pharmacology & Therapeutics 2009;30(7):725-32.
    • (2009) Alimentary Pharmacology & Therapeutics , vol.30 , Issue.7 , pp. 725-732
    • Reimer, C.1    Bytzer, P.2
  • 135
    • 67649222366 scopus 로고    scopus 로고
    • Proton-pump inhibitor therapy induces acid-related symptoms in health volunteers after withdrawal of therapy
    • Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in health volunteers after withdrawal of therapy. Gastroenterology 2009;137(1):80-7.
    • (2009) Gastroenterology , vol.137 , Issue.1 , pp. 80-87
    • Reimer, C.1    Sondergaard, B.2    Hilsted, L.3    Bytzer, P.4
  • 136
    • 84964921069 scopus 로고    scopus 로고
    • Review Manager (RevMan)
    • Version 5.3. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration
    • The Nordic Cochrane Centre: The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2014.
    • (2014)
  • 137
    • 84883746937 scopus 로고    scopus 로고
    • Deciding when to stop: towards evidence-based deprescribing of drugs in older populations
    • Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evidence-Based Medicine 2013;18(4):121-4.
    • (2013) Evidence-Based Medicine , vol.18 , Issue.4 , pp. 121-124
    • Scott, I.A.1    Gray, L.C.2    Martin, J.H.3    Pillans, P.I.4    Mitchell, C.A.5
  • 138
    • 33645048752 scopus 로고    scopus 로고
    • Update on stress ulcer prophylaxis in critically ill patients
    • Spirt MJ, Stanley S. Update on stress ulcer prophylaxis in critically ill patients. Critical Care Nurse 2006;26(1):18-29.
    • (2006) Critical Care Nurse , vol.26 , Issue.1 , pp. 18-29
    • Spirt, M.J.1    Stanley, S.2
  • 140
    • 84905723182 scopus 로고    scopus 로고
    • Deprescribing: what is it and what does the evidence tell us?
    • Thompson W, Farrell B. Deprescribing: what is it and what does the evidence tell us?. Canadian Journal of Hospital Pharmacy 2013;66(3):201-2.
    • (2013) Canadian Journal of Hospital Pharmacy , vol.66 , Issue.3 , pp. 201-202
    • Thompson, W.1    Farrell, B.2
  • 141
    • 0032845018 scopus 로고    scopus 로고
    • Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study
    • Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A. Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. American Journal of Gastroenterology 1999;94(10):2845-54.
    • (1999) American Journal of Gastroenterology , vol.94 , Issue.10 , pp. 2845-2854
    • Tougas, G.1    Chen, Y.2    Hwang, P.3    Liu, M.M.4    Eggleston, A.5
  • 142
    • 33746709974 scopus 로고    scopus 로고
    • The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus
    • Vakil N, Van Zanten SV, Kahrilas P, Dent J, Jones R, Bianchi LK, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. American Journal of Gastroenterology 2006;101(8):1900-20.
    • (2006) American Journal of Gastroenterology , vol.101 , Issue.8 , pp. 1900-1920
    • Vakil, N.1    Van Zanten, S.V.2    Kahrilas, P.3    Dent, J.4    Jones, R.5    Bianchi, L.K.6
  • 144
    • 20444467682 scopus 로고    scopus 로고
    • Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool
    • Veldhuyzen van Zanten SJO, Bradette M, Chiba N, Armstrong D, Barkun A, Flook N, et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Canadian Journal of Gastroenterology 2005;19(5):285-303.
    • (2005) Canadian Journal of Gastroenterology , vol.19 , Issue.5 , pp. 285-303
    • Veldhuyzen van Zanten, S.J.O.1    Bradette, M.2    Chiba, N.3    Armstrong, D.4    Barkun, A.5    Flook, N.6
  • 145
    • 84872171219 scopus 로고    scopus 로고
    • Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria
    • Wahab MSA, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria. International Journal of Clinical Pharmacy 2012;34(6):855-62.
    • (2012) International Journal of Clinical Pharmacy , vol.34 , Issue.6 , pp. 855-862
    • Wahab, M.S.A.1    Nyfort-Hansen, K.2    Kowalski, S.R.3
  • 146
    • 80054745577 scopus 로고    scopus 로고
    • Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease
    • In: Brunton LL, Chabner BA, Knollman CB editor(s).. 12th Edition. New York: McGraw-Hill
    • Wallace JL, Sharkey KA. Pharmacotherapy of gastric acidity, peptic ulcers, and gastroesophageal reflux disease. In: Brunton LL, Chabner BA, Knollman CB editor(s). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th Edition. New York: McGraw-Hill, 2011:1309-22.
    • (2011) Goodman & Gilman's The Pharmacological Basis of Therapeutics , pp. 1309-1322
    • Wallace, J.L.1    Sharkey, K.A.2
  • 147
    • 20444455328 scopus 로고    scopus 로고
    • Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients
    • Zacny J, Zamakhshary M, Sketris I, Veldhuyzen van Zanten S. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients. Alimentary Pharmacology & Therapeutics 2005;21:1299-312.
    • (2005) Alimentary Pharmacology & Therapeutics , vol.21 , pp. 1299-1312
    • Zacny, J.1    Zamakhshary, M.2    Sketris, I.3    Veldhuyzen van Zanten, S.4
  • 148
    • 79960945528 scopus 로고    scopus 로고
    • The challenge of discontinuing proton pump inhibitors
    • Zarowitz B. The challenge of discontinuing proton pump inhibitors. Geriatric Nursing 2011;32(4):276-8.
    • (2011) Geriatric Nursing , vol.32 , Issue.4 , pp. 276-278
    • Zarowitz, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.